Finance

Lists
MED:NYSE
Medifast Inc
USD 12,23
+0,33%
(+0,040) 1D
18 Nov., 13:02:31 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Open
USD 12,13
High
USD 12,27
Low
USD 11,95
Mkt. cap
136,76 m
Avg. vol.
127,07 k
Volume
37,27 k
52-wk high
USD 13,63
52-wk low
USD 9,22
EPS
-USD 3,69
Beta
0,65
Shares outstanding
11,18 m
No. of employees
380
Open
USD 12,13
High
USD 12,27
Low
USD 11,95
Mkt. cap
136,76 m
Avg. vol.
127,07 k
Volume
37,27 k
52-wk high
USD 13,63
52-wk low
USD 9,22
EPS
-USD 3,69
Beta
0,65
Shares outstanding
11,18 m
No. of employees
380
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEODaniel R. Chard | Daniel R. Chard
Employees380
Founded1981
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current USD 12,23
USD 12,00 (-1,88%)
Average
USD 12,00 (-1,88%)
Lowest
USD 12,00 (-1,88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Stephens
Hold
Maintained
USD 12,00
-1,9%
10/27/2026
Jim Salera
Stephens
Hold
Maintained
USD 12,00
-1,9%
10/27/2026
Last report
26 Okt. 2026
Fiscal period
Q3 2026
-USD 0,19 / -USD 0,35
+45,71%beat
Revenue / Est. (USD)
72,05 m / 71,30 m
+1,05%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
75,10 m
76,04 m
76,38 m
72,05 m
Cost of goods sold
22,96 m
24,29 m
22,99 m
22,01 m
Cost of revenue
22,96 m
24,29 m
22,99 m
22,01 m
Research and development expenses
1,00 m
1,10 m
-
2,80 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58,94 m
56,14 m
57,72 m
66,60 m
Operating expense
59,94 m
57,24 m
57,72 m
69,40 m
Total operating expenses
82,90 m
81,52 m
80,71 m
91,41 m
Operating income
-7,80 m
-5,48 m
-4,33 m
-19,36 m
Other non operating income
1,00 k
16,00 k
-11,00 k
15,00 k
EBT including unusual items
-6,38 m
-1,94 m
-2,99 m
-17,84 m
EBT excluding unusual items
-6,38 m
-4,08 m
-2,99 m
-17,84 m
Income tax expense
11,74 m
181,00 k
109,00 k
-324,00 k
Effective tax rate
-183,91%
-9,32%
-3,64%
1,82%
Other operating expenses
-
-
-
-
Net income
-18,12 m
-2,12 m
-3,10 m
-17,51 m
Net profit margin
-24,13%
-2,79%
-4,06%
-24,30%
Earnings per share
-1,65
-0,19
-0,28
-0,19
Interest and investment income
1,42 m
1,38 m
1,35 m
1,51 m
Interest expense
-
-
-
-
Net interest expenses
1,42 m
1,38 m
1,35 m
1,51 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,34 m
-2,00 m
-881,00 k
-17,00 m
Gain or loss from assets sale
372,00 k
-2,12 m
-
362,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme